QTRX

11.18

2.27% -0.26

Handel nachbörslich: 11.18

Quanterix Corp (QTRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$11.44

Offen:

$11.42

24-Stunden-Volumen:

426.25K

Relative Volume:

1.08

Marktkapitalisierung:

$433.30M

Einnahmen:

$121.14M

Nettoeinkommen (Verlust:

$-32.33M

KGV:

-6.3164

EPS:

-1.77

Netto-Cashflow:

$-22.69M

1W Leistung:

-26.98%

1M Leistung:

-12.52%

6M Leistung:

-35.52%

1J Leistung:

-50.20%

1-Tages-Spanne:

$11.03

$11.65

1-Wochen-Bereich:

$11.03

$15.46

52-Wochen-Spanne:

$10.50

$29.70

Quanterix Corp Stock (QTRX) Company Profile

Firmenname

Quanterix Corp

Sektor

Healthcare (1196)

Branche

Medical Devices (153)

Telefon

617-301-9400

Adresse

900 MIDDLESEX TURNPIKE, BILLERICA, MA

Mitarbeiter

141

Twitter

@QuanterixSimoa

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

QTRX's Discussions on Twitter

Vergleichen Sie QTRX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
QTRX	11.18	433.30M	121.14M	-32.33M	-22.69M	-1.77
ABT	117.36	202.64B	41.22B	5.77B	6.49B	2.94
SYK	389.40	150.72B	21.97B	3.59B	3.21B	6.74
BSX	90.45	133.82B	15.91B	1.79B	1.89B	0.82
MDT	87.59	112.98B	32.58B	3.93B	5.15B	2.71
EW	69.89	40.52B	6.60B	4.16B	490.10M	2.34

Quanterix Corp Stock (QTRX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-08-08	Hochstufung	SVB Securities	Market Perform → Outperform
2023-05-23	Hochstufung	Goldman	Neutral → Buy
2022-08-15	Herabstufung	Canaccord Genuity	Buy → Hold
2022-08-09	Herabstufung	Cowen	Outperform → Market Perform
2022-08-09	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2022-03-02	Hochstufung	Goldman	Sell → Neutral
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-06-04	Eingeleitet	Goldman	Sell

Alle ansehen

Quanterix Corp Aktie (QTRX) Neueste Nachrichten

Nov 16, 2024

Quanterix Investors are Encouraged to Contact Kaplan Fox & Kilsheimer LLP Regarding Potential Securities Law Violations - The Globe and Mail

Nov 16, 2024

Nov 15, 2024

Quanterix is Being Investigated for Potential Securities Law ViolationsContact Kaplan Fox & Kilsheimer LLP - The Globe and Mail

Nov 15, 2024

Q3 Earnings Forecast for Quanterix Issued By Leerink Partnrs - MarketBeat

Nov 15, 2024

Quanterix Co. (NASDAQ:QTRX) Short Interest Update - MarketBeat

Nov 15, 2024

Nov 14, 2024

Kaplan Fox & Kilsheimer LLP is Investigating Potential Securities Law Violations Against Quanterix Corp (QTRX) - The Globe and Mail

Nov 14, 2024

Kaplan Fox & Kilsheimer LLP is Investigating Quanterix Corp (QTRX) for Potential Securities Law Violations - The Globe and Mail

Nov 14, 2024

Quanterix stock target raised to $16 on solid revenue growth - Investing.com India

Nov 14, 2024

Nov 13, 2024

Quanterix stock target raised to $16 on solid revenue growth By Investing.com - Investing.com Canada

Nov 13, 2024

Earnings call: Quanterix reports growth with focus on neurology and diagnostics - Investing.com

Nov 13, 2024

The Law Offices of Frank R. Cruz Announces Investigation of Quanterix Corporation (QTRX) on Behalf of Investors - Benzinga

Nov 13, 2024

Portolan Capital Management, LLC Increases Stake in Quanterix Co - GuruFocus.com

Nov 13, 2024

Quanterix earnings beat, revenue topped estimates - Investing.com

Nov 13, 2024

Quanterix Corporation (NASDAQ:QTRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024